Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Oct, 31 2025
Jan, 26 2026
Dec, 15 2025
Jan, 20 2026
Aug, 23 2025